ATE103297T1 - Peptid, immunogene zusammensetzung und impfstoff oder medizinische zubereitung, eine methode zur immunisierung eines saeugetieres gegen lhrh und methode zur verbesserung von mea. - Google Patents

Peptid, immunogene zusammensetzung und impfstoff oder medizinische zubereitung, eine methode zur immunisierung eines saeugetieres gegen lhrh und methode zur verbesserung von mea.

Info

Publication number
ATE103297T1
ATE103297T1 AT90905697T AT90905697T ATE103297T1 AT E103297 T1 ATE103297 T1 AT E103297T1 AT 90905697 T AT90905697 T AT 90905697T AT 90905697 T AT90905697 T AT 90905697T AT E103297 T1 ATE103297 T1 AT E103297T1
Authority
AT
Austria
Prior art keywords
peptide
immunizing
vaccine
immunogenic composition
medicinal preparation
Prior art date
Application number
AT90905697T
Other languages
English (en)
Inventor
Robert Hans Meloen
Cornelis Johannes Gera Wensing
Original Assignee
Stichting Centr Diergeneeskund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Centr Diergeneeskund filed Critical Stichting Centr Diergeneeskund
Application granted granted Critical
Publication of ATE103297T1 publication Critical patent/ATE103297T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT90905697T 1989-03-23 1990-03-22 Peptid, immunogene zusammensetzung und impfstoff oder medizinische zubereitung, eine methode zur immunisierung eines saeugetieres gegen lhrh und methode zur verbesserung von mea. ATE103297T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8900726A NL8900726A (nl) 1989-03-23 1989-03-23 Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.
PCT/NL1990/000037 WO1990011298A1 (en) 1989-03-23 1990-03-22 A peptide, immunogenic composition and vaccine or medicinal preparation; a method of immunising a mammal against lhrh, and a method of improving the meat quality of pigs

Publications (1)

Publication Number Publication Date
ATE103297T1 true ATE103297T1 (de) 1994-04-15

Family

ID=19854349

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90905697T ATE103297T1 (de) 1989-03-23 1990-03-22 Peptid, immunogene zusammensetzung und impfstoff oder medizinische zubereitung, eine methode zur immunisierung eines saeugetieres gegen lhrh und methode zur verbesserung von mea.

Country Status (11)

Country Link
EP (1) EP0464124B1 (de)
JP (1) JP3098771B2 (de)
AT (1) ATE103297T1 (de)
CA (1) CA2049325C (de)
DE (1) DE69007616T2 (de)
DK (1) DK0464124T3 (de)
ES (1) ES2050435T3 (de)
HU (1) HU214742B (de)
NL (1) NL8900726A (de)
RU (1) RU2078770C1 (de)
WO (1) WO1990011298A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
US5171835A (en) * 1988-10-21 1992-12-15 The Administrators Of The Tulane Educational Fund LHRH antagonists
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
PT501882E (pt) * 1991-03-01 2000-12-29 Merial Sas Processo de imunoneutralizacao anti-lhrm de animais domesticos machos nao castrados e peptido para esse fim
US5837268A (en) 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
US5723129A (en) * 1991-10-16 1998-03-03 University Of Saskatchewan GnRH-leukotoxin chimeras
ZA934199B (en) * 1992-06-18 1994-01-10 Akzo Nv Carrier system against gnrh
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
JPH08510260A (ja) * 1993-05-20 1996-10-29 バイオテック・オーストラリア・プロプライエタリー・リミテッド Ｌｈｒｈ拮抗剤
US6761890B1 (en) 1995-06-07 2004-07-13 Pepscan Systems B.V. Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
KR100335320B1 (ko) * 1995-06-07 2002-09-13 스티칭 인스티튜트 부르 디에르후데리지 엔 디에르게존드헤이드 황체호르몬방출호르몬에대한향상된펩티드,면역원성조성물및백신또는의학용제제,동물을면역시키는방법,및황체호르몬방출호르몬직렬반복펩티드의유사체및백신으로서이들의용도
USRE39048E1 (en) 1995-06-07 2006-03-28 Pepscan Systems B.V. Peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
WO1997049425A1 (en) * 1996-06-25 1997-12-31 Stichting Instituut Voor Dierhouderij En Diergezondheid Vaccine comprising antigens bound to carriers through labile bonds
AUPO776897A0 (en) 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
NZ509137A (en) * 1998-06-04 2004-01-30 Metamorphix Internat Inc Methods for reducing GnRH levels in prepubertal vertebrates as an alternative to surgical sterilisation
US6838553B1 (en) * 1999-10-05 2005-01-04 Academia Sinica Peptide repeat immunogens
ES2280402T3 (es) * 2000-09-12 2007-09-16 Pepscan Systems B.V. Discriminacion entre gnrh-i y gnrh-ii.
EP1624884A4 (de) 2003-04-22 2009-08-05 Ipsen Pharma Somatostatin-vektoren
CU23739A1 (es) 2008-09-30 2011-12-28 Ct Ingenieria Genetica Biotech Composición farmacéutica utilizando combinaciones de variantes de la hormona liberadora de las gonadotropinas (gnrh) como inmunógeno
RU2521652C2 (ru) * 2010-12-27 2014-07-10 Общество с ограниченной ответственностью "Научно-внедренческое предприятие "Астрафарм" РЕКОМБИНАНТНАЯ ДНК, КОДИРУЮЩАЯ ГИБРИДНЫЙ ВАКЦИННЫЙ БЕЛОК GHbc ДЛЯ РЕГУЛЯЦИИ ПОЛОВОЙ ФУНКЦИИ У ЖИВОТНЫХ, СОСТОЯЩИЙ ИЗ НУКЛЕОКАПСИДНОГО БЕЛКА ВИРУСА ГЕПАТИТА В ЧЕЛОВЕКА СЛИТОГО С ГОНАДОЛИБЕРИНОМ
WO2016014071A1 (en) * 2014-07-25 2016-01-28 United Biomedical, Inc Immunogenic lhrh composition and use thereof in pigs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608251A (en) * 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
AU602187B2 (en) * 1987-01-14 1990-10-04 Commonwealth Scientific And Industrial Research Organisation Anti-reproductive hormone

Also Published As

Publication number Publication date
EP0464124B1 (de) 1994-03-23
EP0464124A1 (de) 1992-01-08
HU902930D0 (en) 1991-12-30
HU214742B (hu) 1998-10-28
RU2078770C1 (ru) 1997-05-10
DK0464124T3 (da) 1994-05-02
JPH04504256A (ja) 1992-07-30
HUT62916A (en) 1993-06-28
WO1990011298A1 (en) 1990-10-04
CA2049325A1 (en) 1990-09-24
DE69007616D1 (de) 1994-04-28
NL8900726A (nl) 1990-10-16
JP3098771B2 (ja) 2000-10-16
ES2050435T3 (es) 1994-05-16
CA2049325C (en) 2000-07-25
DE69007616T2 (de) 1994-06-30

Similar Documents

Publication Publication Date Title
ATE103297T1 (de) Peptid, immunogene zusammensetzung und impfstoff oder medizinische zubereitung, eine methode zur immunisierung eines saeugetieres gegen lhrh und methode zur verbesserung von mea.
BR9814473A (pt) Imunógenos anti-retrovirais, preparação e uso
HUP9901186A2 (hu) Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
AR018603A1 (es) Un peptido, util para el tratamiento y/o profilaxis de la enfermedad de alzheimer y el sindrome de down, las composiciones farmaceuticas y vacunas que locontienen, el uso de dicho peptido para la preparacion de las composiciones farmaceuticas, una secuencia de aislado de adn, un plasmido o vector vi
ATE269100T1 (de) Verfahren zur therapeutischen impfung
WO2005021707A3 (en) Severe acute respiratory syndrome dna vaccine compositions and methods of use
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
DE69101634D1 (de) Rekombinant hergestellte blutfaktoren, verfahren zur exprimierung besagter blutfaktoren sowie in besagtem prozess verwendeter rekombinanter vaccina-virus.
DE69533102D1 (de) Analog von haemophilus hin47 mit verminderter protease aktivität
BR9812240A (pt) Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênica
FR2746110B1 (fr) Methode de traitement par therapie genique des tumeurs humaines et virus recombinants correspondants
ATE205219T1 (de) Ein verbessertes peptid, immunogene zusammensetzung und impfstoff oder medizinische präparate, eine methode zur immunisierung von tieren gegen das hormon lhrh und analoge des lhrh-tendem-repeat-peptid und deren verwendung als impfstoff
DK0653489T3 (da) Coccidiosisvaccine til fjerkræ
DE69635472D1 (de) Impfstoff gegen Geflügelkokzidose
EP0236977A3 (de) Impfstoffe gegen Rindervirus-Diarrhoe und Schweine-Cholera
DE69521007D1 (de) Impfstoff gegen Geflügelkokzidose
DE69114519D1 (de) Anwendung von il-4 zur steigerung der immunantwort auf immunogene in impfstoffen.
DE69633233D1 (de) Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus
RU98112608A (ru) Иммуногенная композиция [на основе] tlp
DK0938329T3 (da) Immunogen TLP sammensætning
EP2501396A1 (de) Impfung mit niedriger antigendosis zur maximierung von t-helferzellen 1 (t h1)-immunität gegen krankheiten
AR030293A1 (es) Una composicion de vacuna que comprende una proteina receptora de fc; un metodo para prepararla; uso de dicha proteina y de un polinucleotido que codifica para dicha proteina y un metodo para tratar o prevenir una infeccion bacteriana
BR0208771A (pt) Peptìdeo ou poliptìdeo isolados e seus derivados, ácido nucléico codificando o mesmo, vacina copreendendo o mesmo, ácido nucléico codificando o mesmo, vetor compreendendo o referido ácido nucléico, célula hospedeira compreendendo o referido ácido nucléico, composição farmacêutica compreendendo o referido peptìdeo ou polipeptìdeo, método para tratamento ou prevençao de câncer utilizando a referida composição farmacêutica e método para induzir ou magnificar uma resposta imunológica utilizando a referida composição farmacêutica
BR0213554A (pt) Timosina para aumento da imunização genética
AR123724A1 (es) Composiciones y métodos para la prevención y/o tratamiento de la covid-19

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time